id | C00001570 |
---|---|
Name | Jilkon / Lycoremin / Lycoremine / Galanthamine / (-)-Galanthamine |
CAS RN | 357-70-0 |
Standard InChI | InChI=1S/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3/t12-,14-,17-/m0/s1 |
Standard InChI (Main Layer) | InChI=1S/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3 |
Phytochemical cluster | No. 4 |
---|---|
KCF-S cluster | No. 580 |
By standard InChI | CHEMBL659 |
---|---|
By standard InChI Main Layer | CHEMBL659 CHEMBL492193 CHEMBL1565544 CHEMBL1623394 CHEMBL1624158 |
By LinkDB | C08526 |
---|
By CAS RN | D005702 |
---|
class name | count |
---|---|
Liliopsida | 20 |
family name | count |
---|---|
Amaryllidaceae | 20 |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL659 CHEMBL492193 CHEMBL1565544 |
CHEMBL1614110
(3)
CHEMBL1741321
(2)
CHEMBL1909136 (2) |
1 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | CHEMBL659 |
CHEMBL1909139
(2)
|
0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | CHEMBL659 |
CHEMBL1909131
(2)
|
0 / 3 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | CHEMBL659 |
CHEMBL1909190
(2)
|
2 / 2 |
P08246 | Neutrophil elastase | S1A | CHEMBL659 |
CHEMBL1909195
(2)
|
2 / 1 |
P33765 | Adenosine receptor A3 | Adenosine receptor | CHEMBL659 |
CHEMBL1909215
(2)
|
0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | CHEMBL659 |
CHEMBL1909201
(2)
|
0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | CHEMBL659 |
CHEMBL1909176
(2)
|
0 / 0 |
P29466 | Caspase-1 | C14 | CHEMBL659 |
CHEMBL1909193
(2)
|
0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | CHEMBL659 |
CHEMBL1909198
(2)
|
0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | CHEMBL659 |
CHEMBL1909199
(2)
|
0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | CHEMBL659 |
CHEMBL1909197
(2)
|
2 / 2 |
P02545 | Prelamin-A/C | Unclassified protein | CHEMBL659 CHEMBL492193 |
CHEMBL1614544
(2)
|
11 / 10 |
P00918 | Carbonic anhydrase 2 | Lyase | CHEMBL659 |
CHEMBL1909123
(2)
|
1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | CHEMBL659 |
CHEMBL1909092
(2)
|
0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | CHEMBL659 |
CHEMBL1909169
(2)
|
1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | CHEMBL659 |
CHEMBL1909157
(2)
|
0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | CHEMBL659 |
CHEMBL1909156
(2)
|
0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | CHEMBL659 |
CHEMBL1909143
(2)
|
1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | CHEMBL659 |
CHEMBL1909174
(2)
|
0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | CHEMBL659 |
CHEMBL1909090
(2)
|
0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | CHEMBL659 |
CHEMBL1909093
(2)
|
0 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | CHEMBL659 |
CHEMBL1909127
(2)
|
0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | CHEMBL659 |
CHEMBL1909204
(2)
|
0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | CHEMBL659 |
CHEMBL1909202
(2)
|
0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL659 CHEMBL492193 CHEMBL1565544 |
CHEMBL1614027
(1)
CHEMBL1741325
(2)
CHEMBL1909135 (2) |
0 / 1 |
Q13224 | Glutamate receptor ionotropic, NMDA 2B | NS | CHEMBL659 |
CHEMBL1105655
(1)
CHEMBL1105656
(1)
|
1 / 0 |
Q05586 | Glutamate receptor ionotropic, NMDA 1 | NS | CHEMBL659 |
CHEMBL1105653
(1)
CHEMBL1105654
(1)
CHEMBL1105655 (1) CHEMBL1105656 (1) |
1 / 0 |
Q12879 | Glutamate receptor ionotropic, NMDA 2A | NS | CHEMBL659 |
CHEMBL1105653
(1)
CHEMBL1105654
(1)
|
0 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | CHEMBL659 |
CHEMBL1909203
(2)
|
1 / 11 |
P11473 | Vitamin D3 receptor | NR1I1 | CHEMBL659 |
CHEMBL1794311
(1)
|
2 / 3 |
P14416 | D(2) dopamine receptor | Dopamine receptor | CHEMBL659 |
CHEMBL1909140
(2)
|
2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | CHEMBL659 |
CHEMBL1909130
(2)
|
0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | CHEMBL659 |
CHEMBL1909120
(2)
|
0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | CHEMBL659 |
CHEMBL1909181
(2)
|
0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | CHEMBL659 |
CHEMBL1909164
(2)
|
0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | CHEMBL659 |
CHEMBL1909214
(2)
|
0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | CHEMBL659 |
CHEMBL1909175
(2)
|
0 / 0 |
P05067 | Amyloid beta A4 protein | Membrane receptor | CHEMBL659 |
CHEMBL948467
(1)
|
2 / 2 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | CHEMBL659 |
CHEMBL1909096
(2)
|
1 / 1 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | CHEMBL659 |
CHEMBL1909118
(2)
|
0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | CHEMBL659 |
CHEMBL1909166
(2)
|
1 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL659 |
CHEMBL1614458
(1)
|
0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | CHEMBL659 |
CHEMBL1909133
(2)
|
0 / 0 |
Q92630 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | CMGC dual-specificity kinase DYRK2 | CHEMBL659 |
CHEMBL2182309
(1)
|
0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | CHEMBL1623394 |
CHEMBL1738606
(1)
|
0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | CHEMBL659 |
CHEMBL1909158
(2)
|
0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | CHEMBL659 |
CHEMBL1909088
(2)
|
0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | CHEMBL659 |
CHEMBL1909142
(2)
|
0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | CHEMBL659 |
CHEMBL1909101
(2)
|
0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | CHEMBL659 |
CHEMBL1909141
(2)
|
1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | CHEMBL659 |
CHEMBL1909180
(2)
|
0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | CHEMBL659 |
CHEMBL1909146
(2)
|
0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | CHEMBL659 |
CHEMBL1909104
(2)
|
0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | CHEMBL659 |
CHEMBL1909144
(2)
|
0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | CHEMBL659 |
CHEMBL1909100
(2)
|
0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | CHEMBL659 |
CHEMBL1909167
(2)
|
1 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | CHEMBL659 |
CHEMBL1909129
(2)
|
0 / 0 |
P08311 | Cathepsin G | S1A | CHEMBL659 |
CHEMBL1909194
(2)
|
0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | CHEMBL659 |
CHEMBL1909110
(2)
|
1 / 0 |
P03956 | Interstitial collagenase | M10A | CHEMBL659 |
CHEMBL1909196
(2)
|
0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | CHEMBL659 |
CHEMBL1909119
(2)
|
0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | CHEMBL659 |
CHEMBL1909150
(2)
|
0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | CHEMBL659 |
CHEMBL1909171
(2)
|
2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | CHEMBL659 |
CHEMBL1909170
(2)
|
0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | CHEMBL659 |
CHEMBL1909122
(2)
|
0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | CHEMBL659 |
CHEMBL1909109
(2)
|
2 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | CHEMBL659 |
CHEMBL1909205
(2)
|
5 / 10 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | CHEMBL659 |
CHEMBL1909172
(2)
|
1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | CHEMBL659 |
CHEMBL1909114
(2)
|
0 / 0 |
P06276 | Cholinesterase | Hydrolase | CHEMBL659 |
CHEMBL654402
(1)
CHEMBL654405
(1)
CHEMBL656091 (1) CHEMBL841224 (1) CHEMBL829512 (1) CHEMBL861175 (1) CHEMBL859943 (1) CHEMBL911303 (2) CHEMBL895408 (1) CHEMBL900442 (1) CHEMBL948465 (1) CHEMBL998780 (1) CHEMBL978159 (1) CHEMBL965670 (1) CHEMBL1054621 (1) CHEMBL1771987 (1) CHEMBL2162063 (1) CHEMBL2319649 (1) |
0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | CHEMBL659 |
CHEMBL1909125
(2)
|
0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | CHEMBL659 |
CHEMBL1909126
(2)
|
3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | CHEMBL659 |
CHEMBL1909108
(2)
|
0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | CHEMBL659 |
CHEMBL1909124
(2)
|
1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL659 |
CHEMBL1909200
(2)
|
0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | CHEMBL659 |
CHEMBL1909207
(2)
|
2 / 1 |
P56817 | Beta-secretase 1 | A1A | CHEMBL659 |
CHEMBL2050827
(1)
|
0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL659 CHEMBL492193 CHEMBL1565544 |
CHEMBL1741322
(2)
CHEMBL1909132
(2)
|
0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | CHEMBL659 |
CHEMBL1909186
(2)
|
0 / 0 |
P03372 | Estrogen receptor | NR3A1 | CHEMBL659 |
CHEMBL1909145
(2)
|
1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | CHEMBL659 |
CHEMBL1909091
(2)
|
1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | CHEMBL659 |
CHEMBL644110
(1)
CHEMBL644119
(1)
CHEMBL644832 (1) CHEMBL684541 (1) CHEMBL841224 (1) CHEMBL874440 (1) CHEMBL859798 (1) CHEMBL859943 (1) CHEMBL866863 (1) CHEMBL911302 (2) CHEMBL919956 (1) CHEMBL895407 (1) CHEMBL895409 (1) CHEMBL925438 (1) CHEMBL965187 (1) CHEMBL948464 (1) CHEMBL948466 (1) CHEMBL998779 (1) CHEMBL978158 (1) CHEMBL979444 (1) CHEMBL975663 (1) CHEMBL975665 (1) CHEMBL974116 (1) CHEMBL974073 (1) CHEMBL965669 (1) CHEMBL1054620 (1) CHEMBL1042165 (1) CHEMBL1047004 (1) CHEMBL1119101 (1) CHEMBL1227597 (1) CHEMBL1648270 (2) CHEMBL1663835 (1) CHEMBL1671288 (1) CHEMBL1771986 (1) CHEMBL1787066 (1) CHEMBL1787067 (1) CHEMBL1787068 (1) CHEMBL1787069 (1) CHEMBL1809351 (1) CHEMBL1909212 (2) CHEMBL2020014 (1) CHEMBL2050824 (1) CHEMBL2050829 (1) CHEMBL2072352 (1) CHEMBL2162062 (1) CHEMBL2319650 (1) CHEMBL2345676 (1) |
1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | CHEMBL659 |
CHEMBL1909211
(2)
|
0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | CHEMBL659 |
CHEMBL1909105
(2)
|
0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | CHEMBL659 |
CHEMBL1909182
(2)
|
0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | CHEMBL659 |
CHEMBL1909173
(2)
|
0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | CHEMBL659 |
CHEMBL1909113
(2)
|
0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | CHEMBL659 |
CHEMBL1909187
(2)
|
0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | CHEMBL659 |
CHEMBL1909168
(2)
|
0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | CHEMBL492193 |
CHEMBL1614240
(1)
|
0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL659 CHEMBL492193 CHEMBL1565544 |
CHEMBL1613777
(1)
CHEMBL1741323
(2)
CHEMBL1909134 (2) |
1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL659 CHEMBL492193 CHEMBL1565544 |
CHEMBL1029448
(1)
CHEMBL1741324
(2)
CHEMBL1909138 (2) |
0 / 1 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | CHEMBL659 |
CHEMBL1909137
(2)
|
0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | CHEMBL659 |
CHEMBL1909094
(2)
|
1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | CHEMBL659 |
CHEMBL1909087
(2)
|
0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | CHEMBL659 |
CHEMBL1909213
(2)
|
0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | CHEMBL659 |
CHEMBL1909089
(2)
|
0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | CHEMBL659 |
CHEMBL1909116
(2)
|
1 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | CHEMBL659 |
CHEMBL1909206
(2)
|
0 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | CHEMBL659 |
CHEMBL1909128
(2)
|
0 / 0 |
Q13627 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | CMGC dual-specificity kinase DYRK1 | CHEMBL659 |
CHEMBL2182310
(1)
|
1 / 0 |
O00255 | Menin | Unclassified protein | CHEMBL492193 |
CHEMBL1614531
(1)
|
2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | CHEMBL492193 |
CHEMBL1614531
(1)
|
1 / 3 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
D005702 | 43 |
ACHE
ACEE ARACHE N-ACHE YT |
acetylcholinesterase (EC:3.1.1.7) | Galantamine results in decreased activity of ACHE protein |
decreases activity
|
protein |
14535624
18573242 |
D005702 | 1137 |
CHRNA4
BFNC EBN EBN1 NACHR NACHRA4 NACRA4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) | Galantamine binds to [CHRNA4 protein binds to CHRNB2 protein] |
affects binding
|
protein |
15733544
|
D005702 | 1137 |
CHRNA4
BFNC EBN EBN1 NACHR NACHRA4 NACRA4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) | Galantamine inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]] |
affects activity
/ affects binding / decreases reaction |
protein |
15733544
|
D005702 | 1141 |
CHRNB2
EFNL3 nAChRB2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) | Galantamine binds to [CHRNA4 protein binds to CHRNB2 protein] |
affects binding
|
protein |
15733544
|
D005702 | 1141 |
CHRNB2
EFNL3 nAChRB2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) | Galantamine inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]] |
affects activity
/ affects binding / decreases reaction |
protein |
15733544
|
OMIM | preferred title | UniProt |
---|---|---|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#104300 | Alzheimer disease; ad |
P05067
|
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605714 | Cerebral amyloid angiopathy, app-related |
P05067
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#615363 | Estrogen resistance; estrr |
P03372
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
P04626
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#613970 | Mental retardation, autosomal dominant 6; mrd6 |
Q13224
|
#614104 | Mental retardation, autosomal dominant 7; mrd7 |
Q13627
|
#614254 | Mental retardation, autosomal dominant 8; mrd8 |
Q05586
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#159900 | Myoclonic dystonia |
P14416
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | disease name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
|
H00027 | Ovarian cancer |
P04626
(related)
|
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
H00056 | Alzheimer's disease (AD) |
P05067
(related)
|
H01185 | Cerebral amyloid angiopathy (CAA) |
P05067
(related)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00025 | Penile cancer |
P14780
(related)
P35354 (related) |
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
---|---|---|---|---|---|
D000544 | D005702 | Alzheimer Disease |
therapeutic
|
12220392
16274397 16914529 17414243 17926835 18506913 |
|
D000647 | D005702 | Amnesia |
therapeutic
|
1738791
17152362 |
|
D054537 | D005702 | Atrioventricular Block |
marker/mechanism
|
16566422
19008069 |
|
D001321 | D005702 | Autistic Disorder |
therapeutic
|
17069550
|
|
D001919 | D005702 | Bradycardia |
marker/mechanism
|
16566422
19008069 |
|
D003072 | D005702 | Cognition Disorders |
marker/mechanism
therapeutic |
15630600
20184916 |
|
D003693 | D005702 | Delirium |
marker/mechanism
|
18182475
|
|
D015140 | D005702 | Dementia, Vascular |
therapeutic
|
12220392
|
|
D003967 | D005702 | Diarrhea |
marker/mechanism
|
18182475
|
|
D062787 | D005702 | Drug Overdose |
therapeutic
|
603022
|
|
D004421 | D005702 | Dystonia |
marker/mechanism
|
15389998
18506913 |
|
D006261 | D005702 | Headache |
marker/mechanism
|
17069550
|
|
D006948 | D005702 | Hyperkinesis |
therapeutic
|
12721372
|
|
D007022 | D005702 | Hypotension |
marker/mechanism
|
18182475
|
|
D007859 | D005702 | Learning Disorders |
therapeutic
|
17851187
|
|
D008133 | D005702 | Long QT Syndrome |
marker/mechanism
|
16426108
18182475 |
|
D020258 | D005702 | Neurotoxicity Syndromes |
marker/mechanism
|
19782102
|
|
D010243 | D005702 | Paralysis |
therapeutic
|
19647007
|
|
D010259 | D005702 | Paranoid Disorders |
marker/mechanism
|
16274397
|
|
D011041 | D005702 | Poisoning |
therapeutic
|
16914529
|
|
D049188 | D005702 | Prenatal Injuries |
marker/mechanism
|
14657522
|
|
D012640 | D005702 | Seizures |
therapeutic
|
19647007
|
|
D013575 | D005702 | Syncope |
marker/mechanism
|
18182475
|
|
D014202 | D005702 | Tremor |
marker/mechanism
|
8205054
|
|
D014839 | D005702 | Vomiting |
marker/mechanism
|
18182475
19669943 |